CoChat

Convergence of coronary artery disease genes onto endothelial cell programs

Open access
Schnitzler, Gavin R., Kang, Helen, Fang, Shi, Angom, Ramcharan S., Lee-Kim, Vivian S., Ma, X. Rosa, Zhou, Ronghao, Zeng, Tony, Guo, Katherine, Taylor, Martin S., Vellarikkal, Shamsudheen K., Barry, Aurelie E., Sias-Garcia, Oscar, Bloemendal, Alex, Munson, Glen, Guckelberger, Philine, Nguyen, Tung H., Bergman, Drew T., Hinshaw, Stephen, Cheng, Nathan, Cleary, Brian, Aragam, Krishna, Lander, Eric S., Finucane, Hilary K., Mukhopadhyay, Debabrata, Gupta, Rajat M., Engreitz, Jesse M. · 2024 · Nature
Cited by 107

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Linking variants from genome-wide association studies (GWAS) to underlying mechanisms of disease remains a challenge1–3. For some diseases, a successful strategy has been to look for cases in which multiple GWAS loci contain genes that act in the same biological pathway1–6. However, our knowledge of which genes act in which pathways is incomplete, particularly for cell-type-specific pathways or understudied genes. Here we introduce a method to connect GWAS variants to functions. This method links variants to genes using epigenomics data, links genes to pathways de novo using Perturb-seq and integrates these data to identify convergence of GWAS loci onto pathways. We apply this approach to study the role of endothelial cells in genetic risk for coronary artery disease (CAD), and discover 43 CAD GWAS signals that converge on the cerebral cavernous malformation (CCM) signalling pathway. Two regulators of this pathway, CCM2 and TLNRD1, are each linked to a CAD risk variant, regulate other CAD risk genes and affect atheroprotective processes in endothelial cells. These results suggest a model whereby CAD risk is driven in part by the convergence of causal genes onto a particular transcriptional pathway in endothelial cells. They highlight shared genes between common and rare vascular diseases (CAD and CCM), and identify TLNRD1 as a new, previously uncharacterized member of the CCM signalling pathway. This approach will be widely useful for linking variants to functions for other common polygenic diseases. Variant-to-gene-to-program is a new approach to building maps of genome function to link risk variants to disease genes and to convergent signalling pathways in an unbiased manner; its strength is demonstrated in coronary artery disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-024-07022-x

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 84

  1. Weeks, E. M. et al. Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases. Nat. Genet. 55, 1267–1276 (2023). · DOI · Paper page
  2. Westra, H.-J. & Franke, L. From genome to function by studying eQTLs. Biochim. Biophys. Acta 1842, 1896–1902 (2014). · DOI · Paper page
  3. van der Harst, P. & Verweij, N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ. Res. 122, 433–443 (2018). · DOI · Paper page
  4. Tcheandjieu, C. et al. Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. Nat. Med. 28, 1679–1692 (2022). · DOI · Paper page
  5. Aragam, K. G. et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat. Genet. 54, 1803–1815 (2022). · DOI · Paper page
  6. Gimbrone, M. A. Jr & García-Cardeña, G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res. 118, 620–636 (2016). · DOI · Paper page
  7. Turner, A. W. et al. Single-nucleus chromatin accessibility profiling highlights regulatory mechanisms of coronary artery disease risk. Nat. Genet. 54, 804–816 (2022). · DOI · Paper page
  8. Pepin, M. E. & Gupta, R. The role of endothelial cells in atherosclerosis: insights from genetic association studies. Am. J. Pathol. https://doi.org/10.1016/j.ajpath.2023.09.012 (2023). · DOI
  9. Bouïs, D., Hospers, G. A., Meijer, C., Molema, G. & Mulder, N. H. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4, 91–102 (2001). · DOI · Paper page
  10. Nichol, D. & Stuhlmann, H. EGFL7: a unique angiogenic signaling factor in vascular development and disease. Blood 119, 1345–1352 (2012). · DOI · Paper page
  11. Brütsch, R. et al. Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis. Circ. Res. 107, 592–601 (2010). · DOI · Paper page
  12. Stolze, L. K. et al. Systems genetics in human endothelial cells identifies non-coding variants modifying enhancers, expression, and complex disease traits. Am. J. Hum. Genet. 106, 748–763 (2020). · DOI
  13. Wünnemann, F. et al. Multimodal CRISPR perturbations of GWAS loci associated with coronary artery disease in vascular endothelial cells. PLoS Genet. 19, e1010680 (2023). · DOI · Paper page
  14. Stacey, D. et al. ProGeM: a framework for the prioritization of candidate causal genes at molecular quantitative trait loci. Nucleic Acids Res. 47, e3 (2019). · DOI · Paper page
  15. Snellings, D. A. et al. Cerebral cavernous malformation: from mechanism to therapy. Circ. Res. 129, 195–215 (2021). · DOI · Paper page
  16. Zhou, Z. et al. The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression. Dev. Cell 32, 168–180 (2015). · DOI · Paper page
  17. Riolo, G., Ricci, C. & Battistini, S. Molecular genetic features of cerebral cavernous malformations (CCM) patients: an overall view from genes to endothelial cells. Cells 10, 704 (2021). · DOI
  18. Gingras, A. R. et al. Central region of talin has a unique fold that binds vinculin and actin. J. Biol. Chem. 285, 29577–29587 (2010). · DOI · Paper page
  19. Cowell, A. R. et al. Talin rod domain–containing protein 1 (TLNRD1) is a novel actin-bundling protein which promotes filopodia formation. J. Cell Biol. 220, e202005214 (2021). · DOI
  20. Fisher, O. S. et al. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations. J. Biol. Chem. 290, 2842–2853 (2015). · DOI · Paper page
  21. Draheim, K. M. et al. CCM2–CCM3 interaction stabilizes their protein expression and permits endothelial network formation. J. Cell Biol. 208, 987–1001 (2015). · DOI
  22. Zhou, Z. et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 532, 122–126 (2016). · DOI · Paper page
  23. Renz, M. et al. Regulation of β1 integrin–Klf2-mediated angiogenesis by CCM proteins. Dev. Cell 32, 181–190 (2015). · DOI
  24. Donat, S. et al. Heg1 and Ccm1/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis. eLife 7, e28939 (2018). · DOI
  25. Khera, A. V. et al. Gene sequencing identifies perturbation in nitric oxide signaling as a nonlipid molecular subtype of coronary artery disease. Circ. Genom. Precis. Med. 15, e003598 (2022). · DOI
  26. Macek Jilkova, Z. et al. CCM proteins control endothelial β1 integrin dependent response to shear stress. Biol. Open 3, 1228–1235 (2014). · DOI
  27. Knowles, J. W. et al. Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment. J. Clin. Invest. 105, 451–458 (2000). · DOI · Paper page
  28. Mueller, P. A. et al. Coronary artery disease risk-associated Plpp3 gene and its product lipid phosphate phosphatase 3 regulate experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 39, 2261–2272 (2019). · DOI
  29. Denier, C. et al. Genotype–phenotype correlations in cerebral cavernous malformations patients. Ann. Neurol. 60, 550–556 (2006). · DOI · Paper page
  30. Whitehead, K. J. et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 15, 177–184 (2009). · DOI · Paper page
  31. Zheng, X. et al. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J. Clin. Invest. 120, 2795–2804 (2010). · DOI · Paper page
  32. Chen, Y., Lun, A. T. L. & Smyth, G. K. From reads to genes to pathways: differential expression analysis of RNA-seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Research 5, 1438 (2016).
  33. Marshall, J. L. et al. HyPR-seq: single-cell quantification of chosen RNAs via hybridization and sequencing of DNA probes. Proc. Natl Acad. Sci. USA 117, 33404–33413 (2020). · DOI
  34. Hart, T. & Moffat, J. BAGEL: a computational framework for identifying essential genes from pooled library screens. BMC Bioinformatics 17, 164 (2016). · DOI · Paper page
  35. Nygaard, V., Rødland, E. A. & Hovig, E. Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses. Biostatistics 17, 29–39 (2016). · DOI · Paper page
  36. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010). · DOI · Paper page
  37. Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
  38. Karolchik, D., Hinrichs, A. S. & James Kent, W. The UCSC genome browser. Curr. Protoc. Hum. Genet. 71, 18.6.1–18.6.33 (2011).
  39. Wirka, R. C. et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat. Med. 25, 1280–1289 (2019). · DOI · Paper page
  40. Dey, K. K. et al. Contribution of enhancer-driven and master-regulator genes to autoimmune disease revealed using functionally informed SNP-to-gene linking strategies. Cell Genomics 2, 100145 (2022). · DOI
  41. Zhang, K. et al. A single-cell atlas of chromatin accessibility in the human genome. Cell 184, 5985–6001.e19 (2021). · DOI · Paper page
  42. Hujoel, M. L. A., Gazal, S., Hormozdiari, F., van de Geijn, B. & Price, A. L. Disease heritability enrichment of regulatory elements is concentrated in elements with ancient sequence age and conserved function across species. Am. J. Hum. Genet. 104, 611–624 (2019). · DOI
  43. Padarti, A. & Zhang, J. Recent advances in cerebral cavernous malformation research. Vessel Plus 2, 21 (2018). · DOI
  44. Wei, S. et al. Cerebral cavernous malformation proteins in barrier maintenance and regulation. Int. J. Mol. Sci. 21, 675 (2020). · DOI
  45. Cullere, X., Plovie, E., Bennett, P. M., MacRae, C. A. & Mayadas, T. N. The cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3. Proc. Natl Acad. Sci. USA 112, 14284–14289 (2015). · DOI · Paper page
  46. Kleaveland, B. et al. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 15, 169–176 (2009). · DOI · Paper page
  47. Atri, D. S. et al. CRISPR–Cas9 genome editing of primary human vascular cells in vitro. Curr Protoc. 1, e291 (2021). · DOI
  48. Higaki, T. Quantitative evaluation of cytoskeletal organizations by microscopic image analysis. Plant Morphol. 29, 15–21 (2017). · DOI
  49. Kroll, F. et al. A simple and effective F0 knockout method for rapid screening of behaviour and other complex phenotypes. eLife 10, e59683 (2021). · DOI · Paper page
  50. Lu, F., Leach, L. L. & Gross, J. M. A CRISPR–Cas9-mediated F0 screen to identify pro-regenerative genes in the zebrafish retinal pigment epithelium. Sci. Rep. 13, 3142 (2023). · DOI
  51. Moulton, J. D. & Yan, Y.-L. Using morpholinos to control gene expression. Curr. Protoc. Mol. Biol. Chapter 26, Unit 26.8 (2008).
  52. Hoeppner, L. H. et al. Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability. Blood 120, 2167–2173 (2012). · DOI
  53. Wang, Y. et al. Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: essential roles of dimethylarginine dimethylaminohydrolase-1. iScience 24, 103189 (2021). · DOI
  54. Zebrafish embryo medium. Cold Spring Harb. Protoc. 2011, db.rec12478 (2011). · doi:10.1101/pdb.rec12478
  55. Machikhin, A. S., Volkov, M. V., Burlakov, A. B., Khokhlov, D. D. & Potemkin, A. V. Blood vessel imaging at pre-larval stages of zebrafish embryonic development. Diagnostics 10, 886 (2020). · DOI
  56. Thisse, C. & Thisse, B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat. Protoc. 3, 59–69 (2008). · DOI · Paper page
  57. Hodonsky, C. J. et al. Multi-ancestry genetic analysis of gene regulation in coronary arteries prioritizes disease risk loci. Cell Genomics 4, 100465 (2024). · DOI
  58. Li, L. et al. Transcriptome-wide association study of coronary artery disease identifies novel susceptibility genes. Basic Res. Cardiol. 117, 6 (2022). · DOI
  59. Stuart, T. et al. Comprehensive integration of single-Cell data. Cell 177, 1888–1902.e21 (2019). · DOI · Paper page
  60. Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015). · DOI · Paper page
  61. Wickham, H. ggplot2 (Springer-Verlag, 2016). · DOI · Paper page
  62. Gagolewski, M. stringi: fast and portable character string processing in R. J. Stat. Softw. 103, 1–59 (2022). · DOI · Paper page
  63. Holt, J., Huang, S., McMillan, L. & Wang, W. Read annotation pipeline for high-throughput sequencing data. In Proc. International Conference on Bioinformatics, Computational Biology and Biomedical Informatics 605–612 (Association for Computing Machinery, 2013). · DOI
  64. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009). · DOI · Paper page
  65. Langmead, B., Wilks, C., Antonescu, V. & Charles, R. Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics 35, 421–432 (2019). · DOI · Paper page
  66. Gaspar, J. M. Improved peak-calling with MACS2. Preprint at bioRxiv https://doi.org/10.1101/496521 (2018). · DOI · Paper page
  67. Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011). · DOI · Paper page
  68. Ghoussaini, M. et al. Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 49, D1311–D1320 (2021). · DOI · Paper page
  69. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007). · DOI · Paper page
  70. Boughton, A. P. et al. LocusZoom.js: interactive and embeddable visualization of genetic association study results. Bioinformatics 37, 3017–3018 (2021). · DOI · Paper page
  71. Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564–576.e16 (2017). · DOI · Paper page
  72. Alcid, E. A. & Tsukiyama, T. ATP-dependent chromatin remodeling shapes the long noncoding RNA landscape. Genes Dev. 28, 2348–2360 (2014). · DOI
  73. SenBanerjee, S. et al. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199, 1305–1315 (2004). · DOI · Paper page
  74. Coma, S. et al. GATA2 and LMO2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2. Angiogenesis 16, 939–952 (2013). · DOI
  75. Yu, M. et al. Computational estimates of annular diameter reveal genetic determinants of mitral valve function and disease. JCI Insight 7, e146580 (2022). · DOI
  76. Hogan, B. M., Bussmann, J., Wolburg, H. & Schulte-Merker, S. ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum. Mol. Genet. 17, 2424–2432 (2008). · DOI
  77. Neuman, N. A. et al. The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone. J. Biol. Chem. 284, 13202–13212 (2009). · DOI
  78. Wang, W. et al. Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ. Res. 98, 1032–1039 (2006). · DOI · Paper page
  79. Tsai, S. et al. TGF-β through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation. Am. J. Physiol. Heart Circ. Physiol. 297, H540–H549 (2009). · DOI · Paper page
  80. Crispino, J. D. & Weiss, M. J. Erythro-megakaryocytic transcription factors associated with hereditary anemia. Blood 123, 3080–3088 (2014). · DOI
  81. Gruber, T. A. & Downing, J. R. The biology of pediatric acute megakaryoblastic leukemia. Blood 126, 943–949 (2015). · DOI
  82. Hauser, W. et al. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc. Natl Acad. Sci. USA 96, 8120–8125 (1999). · DOI · Paper page
  83. Pleines, I. et al. Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia. J. Clin. Invest. 127, 814–829 (2017). · DOI
  84. Meinders, M. et al. Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function. Blood 125, 1957–1967 (2015). · DOI

Cited by

See all 107

Metadata

Authors
Schnitzler, G. R., Kang, H., Fang, S., Angom, R. S., Lee-Kim, V. S., Ma, X. R., Zhou, R., Zeng, T., Guo, K., Taylor, M. S., Vellarikkal, S. K., Barry, A. E., Sias-Garcia, O., Bloemendal, A., Munson, G., Guckelberger, P., Nguyen, T. H., Bergman, D. T., Hinshaw, S., Cheng, N., Cleary, B., Aragam, K., Lander, E. S., Finucane, H. K., Mukhopadhyay, D., Gupta, R. M., & Engreitz, J. M.
Venue
Nature
Published
2024-02-07
Volume
626
Issue
8000
Pages
799-807
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4391617379
Cited by
107
References
47
FWCI
25.88
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Convergence of coronary artery disease genes onto endothelial cell programs. https://app.cochat.ai/papers/10.1038/s41586-024-07022-x
The paper
Schnitzler, G. R., Kang, H., Fang, S., Angom, R. S., Lee-Kim, V. S., Ma, X. R., Zhou, R., Zeng, T., Guo, K., Taylor, M. S., Vellarikkal, S. K., Barry, A. E., Sias-Garcia, O., Bloemendal, A., Munson, G., Guckelberger, P., Nguyen, T. H., Bergman, D. T., Hinshaw, S., . . . Engreitz, J. M. (2024). Convergence of coronary artery disease genes onto endothelial cell programs. Nature. https://doi.org/10.1038/s41586-024-07022-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.